Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP331650.RAV9NoW-GB_Kh8lLIs7WYBw_wnDNc77fhzL0brhYx7UO0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP331650.RAV9NoW-GB_Kh8lLIs7WYBw_wnDNc77fhzL0brhYx7UO0130_assertion type Assertion NP331650.RAV9NoW-GB_Kh8lLIs7WYBw_wnDNc77fhzL0brhYx7UO0130_head.
- NP331650.RAV9NoW-GB_Kh8lLIs7WYBw_wnDNc77fhzL0brhYx7UO0130_assertion description "[The prevalences of activated protein C resistance (APCR), factor V Leiden positivity, elevated PAI-1 and Lp(a) levels were significantly higher in patients with respect to controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331650.RAV9NoW-GB_Kh8lLIs7WYBw_wnDNc77fhzL0brhYx7UO0130_provenance.
- NP331650.RAV9NoW-GB_Kh8lLIs7WYBw_wnDNc77fhzL0brhYx7UO0130_assertion evidence source_evidence_literature NP331650.RAV9NoW-GB_Kh8lLIs7WYBw_wnDNc77fhzL0brhYx7UO0130_provenance.
- NP331650.RAV9NoW-GB_Kh8lLIs7WYBw_wnDNc77fhzL0brhYx7UO0130_assertion SIO_000772 11583306 NP331650.RAV9NoW-GB_Kh8lLIs7WYBw_wnDNc77fhzL0brhYx7UO0130_provenance.
- NP331650.RAV9NoW-GB_Kh8lLIs7WYBw_wnDNc77fhzL0brhYx7UO0130_assertion wasDerivedFrom befree-2016 NP331650.RAV9NoW-GB_Kh8lLIs7WYBw_wnDNc77fhzL0brhYx7UO0130_provenance.
- NP331650.RAV9NoW-GB_Kh8lLIs7WYBw_wnDNc77fhzL0brhYx7UO0130_assertion wasGeneratedBy ECO_0000203 NP331650.RAV9NoW-GB_Kh8lLIs7WYBw_wnDNc77fhzL0brhYx7UO0130_provenance.